|
|
|
Volumn 19, Issue 2, 2003, Pages 135-139
|
|
Early report of randomized double blind clinical trial of hormonal therapy of carcinoma of prostate (CaP) stage D2
a
|
|
Author keywords
Advanced carcinoma of prostate; Bony metastasis; Combined androgen blockade
|
|
Indexed keywords
ANDROGEN;
ANTIANDROGEN;
FLUTAMIDE;
PLACEBO;
PROSTATE SPECIFIC ANTIGEN;
SEX HORMONE;
ADVANCED CANCER;
ARTICLE;
BONE METASTASIS;
BONE SCINTISCANNING;
CANCER GROWTH;
CANCER HORMONE THERAPY;
CANCER SIZE;
CANCER STAGING;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE SEVERITY;
DOUBLE BLIND PROCEDURE;
DRUG POTENTIATION;
DRUG RESPONSE;
FOLLOW UP;
HORMONE INHIBITION;
HUMAN;
IMAGING SYSTEM;
INDIAN;
MAJOR CLINICAL STUDY;
MALE;
MONOTHERAPY;
ORCHIECTOMY;
PROSTATE CARCINOMA;
RANDOMIZED CONTROLLED TRIAL;
SCORING SYSTEM;
SEROLOGY;
SKELETON RADIOGRAPHY;
TREATMENT FAILURE;
TREATMENT OUTCOME;
TREATMENT PLANNING;
|
|
EID: 0037395656
PISSN: 09701591
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (1)
|
|
References (7)
|
